Patent US4529587A successfully refreshed from Google Patents.
US4529587A
Expired / Lapsed
US
⏱️ 0.0 years remaining
Method of reducing sebum on the hair and skin
Assignee: CPPD Inc A CORP OF
•
Filing: 1983-02-01
•
Granted: 1985-07-16
•
Expires: 2003-02-01
Abstract
Abstract A cosmetically acceptable composition for topical application to human skin or hair in order to reduce greasiness comprises, at a concentration of from 0.0001M to 0.5M, a biotin antagonist which is capable of blocking the activity of the biotin dependent enzyme acetyl-SCoA-carboxylase implicated in sebum production; together with a carrier other than water as an aid to delivering the biotin antagonist to the sebaceous gland.
Inventors
- 👤 Martin R. Green
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-11-09 19:46
CPC Classifications
A; A61; A61Q; A61Q19/00; A61Q19/008; A61K; A61K8/00; A61K8/18; A61K8/30; A61K8/67; A61P; A61P17/00; A61Q5/00; A61Q5/008; Y; Y10; Y10S; Y10S424/00; Y10S424/04
Claims Analysis
Total Claims: 20
Claim 1
Independent Claim
124 words
A method of treating human skin or hair to reduce the amount of sebum secreted onto the skin surface or hair which comprises contacting said skin or hair with an effective sebum reducng amount of a composition which comprises, at a concentration of from about 0.004% to about 10% by weight of the composition, a biotin antagonist, or a salt thereof, or mixtures thereof, which is capable of blocking the activity of the biotin-dependent enzyme acetyl-SCoA-carboxylase, involved in lipid synthesis and located in sebaceous glands of the skin; together with a carrier selected from the group consisting of liquid other than water, cream, gel, powder, lotion, emulsion, shampoo and mixtures thereof said carrier being capable of conveying said biotin antagonist to said sebaceous glands.
Claim 2
Independent Claim
124 words
A method of treating human skin or hair to reduce the amount of sebum secreted onto the skin surface or hair which comprises contacting said skin or hair with an effective sebum reducng amount of a composition which comprises, at a concentration of from about 0.004% to about 10% by weight of the composition, a biotin antagonist, or a salt thereof, or mixtures thereof, which is capable of blocking the activity of the biotin-dependent enzyme acetyl-SCoA-carboxylase, involved in lipid synthesis and located in sebaceous glands of the skin; together with a carrier selected from the group consisting of liquid other than water, cream, gel, powder, lotion, emulsion, shampoo and mixtures thereof said carrier being capable of conveying said biotin antagonist to said sebaceous glands.
Claim 3
Dependent Claim
128 words
The method according to claim 1, wherein the biotin antagonist has the structure (I): ##STR7## where n is zero or 1 and when n is zero, X is --CH 3 , and Y is --(CH 2 ) m Z and when n is 1, R is chosen from >O, >S, >S═O or ##STR8## X is >CH 2 , and Y is >CH(CH 2 ) m-1 Z where m is an integer of from 1 to 8, and Z is chosen from --CH 2 COOH, --CH═CHCOOH, --CH(CH 3 )COOH, --CH 2 COOCH 3 , --NHNH 2 and --SO 3 H provided that when n is 1, R is S, and Z is --CH 2 COOH, then m is an integer of from 1 to 3, or 5 to 8.
Claim 4
Dependent Claim
28 words
The method according to claim 2, wherein the biotin antagonist is selected from the group consisting of trisnordesthiobiotin, bisnordesthiobiotin, nordesthiobiotin, desthiobiotin, homodesthiobiotin, bishomodesthiobiotin, trishomodesthiobiotin tetrahomodesthiobiotin, and mixtures thereof.
Claim 5
Dependent Claim
12 words
The method according to claim 2, wherein the biotin antagonist is α-methyldesthiobiotin.
Claim 6
Dependent Claim
34 words
The method according to claim 2, wherein the biotin antagonist is selected from the group consisting of trisnorbiotin sulphoxide, bisnorbiotin sulphoxide, norbiotin sulphoxide, biotin sulphoxide, homobiotin sulphoxide, bishomobiotin sulphoxide, trishomobiotin sulphoxide and mixtures thereof.
Claim 7
Dependent Claim
34 words
The method according to claim 2, wherein the biotin antagonist is selected from the group consisting of trisnorbiotin sulphone, bisnorbiotin sulphone, norbiotin sulphone, biotin sulphone, homobiotin sulphone, bishomobiotin sulphone, trishomobiotin sulphone and mixtures thereof.
Claim 8
Dependent Claim
26 words
The method according to claim 2, wherein the biotin antagonist is selected from the group consisting of trisnorbiotin, bisnorbiotin, norbiotin, homobiotin, bishomobiotin, trishomobiotin, and mixtures thereof.
Claim 9
Dependent Claim
23 words
The method according to claim 2, wherein the biotin antagonist is selected from the group consisting of α-dehydrobiotin, α-methylbiotin and a mixture thereof.
Claim 10
Dependent Claim
27 words
The method according to claim 2, wherein the biotin antagonist is selected from the group consisting of trisnoroxybiotin, bisnoroxybiotin, noroxybiotin, oxybiotin, homooxybiotin, bishomooxybiotin, trishomooxybiotin, and mixtures thereof.
Claim 11
Dependent Claim
41 words
The method according to claim 2, wherein the biotin antagonist is selected from the group consisting of trisnoroxybiotin sulphonic acid, bisnoroxybiotin sulphonic acid, noroxybiotin sulphonic acid, oxybiotin sulphonic acid, homooxybiotin sulphonic acid, bishomooxybiotin sulphonic acid, trishomooxybiotin sulphonic acid, and mixtures thereof.
Claim 12
Dependent Claim
41 words
The method according to claim 2, wherein the biotin antagonist is selected from the group consisting of trisnorbiotin methyl ester, bisnorbiotin methyl ester, norbiotin methyl ester, homobiotin methyl ester, bishomobiotin methyl ester, trishomobiotin methyl ester, tetrahomobiotin methyl ester, and mixtures thereof.
Claim 13
Dependent Claim
52 words
The method according to claim 2, wherein the biotin antagonist is selected from the group consisting of trisnorbiotin sulphone methyl ester, bisnorbiotin sulphone methyl ester, norbiotin sulphone methyl ester, biotin sulphone methyl ester, homobiotin sulphone methyl ester, bishomobiotin sulphone methyl ester, trishomobiotin sulphone methyl ester, tetrahomobiotin sulphone methyl ester, and mixtures thereof.
Claim 14
Dependent Claim
34 words
The method according to claim 2, wherein the biotin antagonist is selected from the group consisting of trisnorbiotin hydrazide, bisnorbiotin hydrazide, norbiotin hydrazide, biotin hydrazide, homobiotin hydrazide, bishomobiotin hydrazide, trishomobiotin hydrazide, and mixtures thereof.
Claim 15
Dependent Claim
24 words
The method according to claim 1, wherein the biotin antagonist has the structure: ##STR9## where p is an integer of from 2 to 5.
Claim 16
Dependent Claim
32 words
The method according to claim 14, wherein the biotin antagonist having the structure (II) is selected from the group consisting of: γ-(2,3-ureylenecyclohexyl)butyric acid, δ-(2,3-ureylenecyclohexyl)valeric acid, γ-(3,4-ureylenecyclohexyl)butyric acid, δ-(3,4-ureylenecyclohexyl)valeric acid, and mixtures thereof.
Claim 17
Dependent Claim
65 words
The method according to claim 1, wherein the biotin antagonist is selected from the group consisting of: 2-oxo-4-imidazolidine caproic acid, thiazolidine, methyl-1,3-acetyl-4-thiazolidine carboxylate, 1,2-propyl-2-acetyl-4-thiazolidine carboxylate methyl ester, and its hydrazide, 2-piperidone-6-carboxylic acid hydrazide, γ-(2-carboxy-3-indolyl)butyric acid hydrazide, 2-imidazoline-4-carboxylic acid hydrazide, 2-imidazoline-4-caproic acid hydrazide, 2-imidazoline-4-valeric acid hydrazide, ureylenetetrahydrofuryl aliphatic sulphonic acids, benzyl thio esters, semicarbazides of biotin, bishydrazides of suberic acid and sebacic acids, and mixtures thereof.
Claim 18
Dependent Claim
32 words
The method according to claim 1, wherein the carrier other than water is a C 1 to C 4 alkanol selected from the group consisting of ethanol, propane-1-ol, propane-2-ol and mixtures thereof.
Claim 19
Dependent Claim
59 words
The method according to claim 1, wherein the carrier is a powder selected from the group consisting of chalk, talc, fullers earth, kaolin, starch, gums, colloidal silicon dioxide, sodium polyacrylate, tetra-alkyl arylammonium smectite, tri-alkyl arylammonium smectite, chemically modified magnesium aluminum silicate, organically modified montmorillonite clay, hydrated aluminum silicate, fumed silica, carboxyvinyl polymer, sodium carboxymethyl cellulose, and ethylene glycol monostearate.
Claim 20
Dependent Claim
10 words
The method according to claim 1, which further comprises water.
References Cited (Backward Citations)
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 1988-07-15 | 1989-01-14 | 1989-07-16 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 1992-07-15 | 1993-01-14 | 1993-07-16 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 1996-07-15 | 1997-01-14 | 1997-07-16 | $7700.00 | Window Closed / Lapsed |